利用基因组工程攻克神经退行性疾病：NIH 的一项新干细胞计划。
Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH.
机构信息
Center for Alzheimer's Disease and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
出版信息
Neuron. 2021 Apr 7;109(7):1080-1083. doi: 10.1016/j.neuron.2021.03.022.
Abstract
The iPSC Neurodegenerative Disease Initiative (iNDI) is the largest-ever iPSC genome engineering project. iNDI will model more than 100 mutations associated with Alzheimer's disease and related dementias (ADRD) in isogenic iPSC lines. Resulting cell lines and phenotypic datasets will be broadly shared.
摘要
iPSC 神经退行性疾病计划（iNDI）是有史以来规模最大的 iPSC 基因组工程计划。iNDI 将在同基因 iPSC 系中模拟超过 100 种与阿尔茨海默病和相关痴呆症（ADRD）相关的突变。产生的细胞系和表型数据集将被广泛共享。
相似文献
1
Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH.利用基因组工程攻克神经退行性疾病：NIH 的一项新干细胞计划。
Neuron. 2021 Apr 7;109(7):1080-1083. doi: 10.1016/j.neuron.2021.03.022.
2
Methods of Generation of Induced Pluripotent Stem Cells and Their Application for the Therapy of Central Nervous System Diseases.诱导多能干细胞的生成方法及其在中枢神经系统疾病治疗中的应用。
Bull Exp Biol Med. 2020 Feb;168(4):566-573. doi: 10.1007/s10517-020-04754-4. Epub 2020 Mar 10.
3
Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.利用多能干细胞技术对人类神经退行性疾病进行逆向工程研究。
Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.
4
Neural stem cell-based treatment for neurodegenerative diseases.基于神经干细胞的神经退行性疾病治疗方法。
Neuropathology. 2013 Oct;33(5):491-504. doi: 10.1111/neup.12020. Epub 2013 Feb 5.
5
Developing neural stem cell-based treatments for neurodegenerative diseases.开发基于神经干细胞的神经退行性疾病治疗方法。
Stem Cell Res Ther. 2014 May 30;5(3):72. doi: 10.1186/scrt461.
6
Human embryonic stem cell therapies for neurodegenerative diseases.用于神经退行性疾病的人胚胎干细胞治疗。
CNS Neurol Disord Drug Targets. 2011 Jun;10(4):440-8. doi: 10.2174/187152711795564001.
7
Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery.培养皿中的神经退行性疾病：诱导多能干细胞技术在疾病建模和治疗发现中的前景
Neurol Sci. 2015 Jan;36(1):21-7. doi: 10.1007/s10072-014-1989-9. Epub 2014 Oct 30.
8
Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.直接重编程的神经元细胞作为细胞移植治疗的一种新资源。
Cell Transplant. 2014;23(4-5):435-9. doi: 10.3727/096368914X678274. Epub 2014 Mar 11.
9
Harnessing diversity to study Alzheimer's disease: A new iPSC resource from the NIH CARD and ADNI.利用多样性研究阿尔茨海默病：美国国立卫生研究院细胞和组织库及阿尔茨海默病神经成像计划的一项新的诱导多能干细胞资源。
Neuron. 2024 Mar 6;112(5):694-697. doi: 10.1016/j.neuron.2024.01.026. Epub 2024 Feb 21.
10
Stem Cell Technology for (Epi)genetic Brain Disorders.用于（表观）遗传脑疾病的干细胞技术
Adv Exp Med Biol. 2017;978:443-475. doi: 10.1007/978-3-319-53889-1_23.
引用本文的文献
1
CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer's disease.几丁质酶3样蛋白1/壳多糖酶-3样蛋白40（CHI3L1/YKL-40）信号通路在阿尔茨海默病模型中抑制神经发生。
Sci Adv. 2025 Jul 18;11(29):eadv1492. doi: 10.1126/sciadv.adv1492.
2
Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism.葡糖脑苷脂酶缺乏对戈谢病和帕金森病患者同基因多巴胺能神经元中糖蛋白非转移性黑色素瘤蛋白B的双向调节
bioRxiv. 2025 Jun 25:2025.06.23.661126. doi: 10.1101/2025.06.23.661126.
3
Large-scale HLA immunopeptidome and interactome profiling in microglia.小胶质细胞中大规模HLA免疫肽组和相互作用组分析
bioRxiv. 2025 Apr 26:2025.04.23.650327. doi: 10.1101/2025.04.23.650327.
4
Non-coding variation in dementias: mechanisms, insights, and challenges.痴呆症中的非编码变异：机制、见解与挑战。
NPJ Dement. 2025;1(1):9. doi: 10.1038/s44400-025-00012-4. Epub 2025 Jun 3.
5
Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative.体细胞与干细胞库研究非洲血统对痴呆症的影响：非洲诱导多能干细胞计划。
Alzheimers Dement. 2025 Apr;21(4):e70145. doi: 10.1002/alz.70145.
6
Somatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC Initiative.体细胞与干细胞库研究非洲血统对痴呆症的影响：非洲诱导多能干细胞计划
medRxiv. 2025 Jan 27:2025.01.24.25320911. doi: 10.1101/2025.01.24.25320911.
7
Amyloid-β can activate JNK signalling via WNT5A-ROR2 to reduce synapse formation in Alzheimer's disease.淀粉样蛋白β可通过WNT5A-ROR2激活JNK信号通路，以减少阿尔茨海默病中的突触形成。
J Cell Sci. 2025 Feb 1;138(3). doi: 10.1242/jcs.263526. Epub 2025 Feb 5.
8
Protocol for live imaging of axonal transport in iPSC-derived iNeurons.诱导多能干细胞衍生的诱导神经元轴突运输活体成像方案。
STAR Protoc. 2025 Mar 21;6(1):103556. doi: 10.1016/j.xpro.2024.103556. Epub 2025 Jan 12.
9
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.整合多组学揭示了家族性阿尔茨海默病中PSEN1、PSEN2和APP突变的常见内型。
Alzheimers Res Ther. 2025 Jan 4;17(1):5. doi: 10.1186/s13195-024-01659-6.
10
Endo-IP and lyso-IP toolkit for endolysosomal profiling of human-induced neurons.用于人诱导神经元内溶酶体分析的Endo-IP和lyso-IP工具包。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2419079121. doi: 10.1073/pnas.2419079121. Epub 2024 Dec 5.
本文引用的文献
1
Models of Neurodegenerative Diseases.神经退行性疾病模型
Front Cell Dev Biol. 2020 May 13;8:328. doi: 10.3389/fcell.2020.00328. eCollection 2020.
2
A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.原发性 Tau 病患者诱导多能干细胞的综合资源。
Stem Cell Reports. 2019 Nov 12;13(5):939-955. doi: 10.1016/j.stemcr.2019.09.006. Epub 2019 Oct 17.
3
PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia.PSEN1ΔE9、APPswe 和 APOE4 在人诱导多能干细胞源性小胶质细胞中导致不同表型。
Stem Cell Reports. 2019 Oct 8;13(4):669-683. doi: 10.1016/j.stemcr.2019.08.004. Epub 2019 Sep 12.
4
A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.一个包含大量同基因 APP 和 PSEN1 突变的人 iPSC 神经元的大面板揭示了由 APP β-CTFs 介导的共享内体异常，而不是 Aβ。
Neuron. 2019 Oct 23;104(2):256-270.e5. doi: 10.1016/j.neuron.2019.07.010. Epub 2019 Aug 12.
5
Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.通过高通量筛选鉴定降低 Tau 化合物的 iPSC 衍生人神经元的可扩展生产。
Stem Cell Reports. 2017 Oct 10;9(4):1221-1233. doi: 10.1016/j.stemcr.2017.08.019. Epub 2017 Sep 28.
6
iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.用于研究神经疾病的诱导多能干细胞衍生的人小胶质细胞样细胞
Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042.
7
The human-induced pluripotent stem cell initiative-data resources for cellular genetics.人类诱导多能干细胞计划——细胞遗传学的数据资源
Nucleic Acids Res. 2017 Jan 4;45(D1):D691-D697. doi: 10.1093/nar/gkw928. Epub 2016 Oct 12.
8
CRISPR/Cas9 for Human Genome Engineering and Disease Research.用于人类基因组工程和疾病研究的CRISPR/Cas9技术
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:131-54. doi: 10.1146/annurev-genom-083115-022258. Epub 2016 May 23.
9
The Parkinson Progression Marker Initiative (PPMI).帕金森进展标志物倡议（PPMI）。
Prog Neurobiol. 2011 Dec;95(4):629-35. doi: 10.1016/j.pneurobio.2011.09.005. Epub 2011 Sep 14.
Zotero 插件